AS exerts therapeutic effect in ALI by promoting miRNA-21 expression, inhibiting the Sema4D/CD72/NF-κB signaling pathway and mitochondrial dysfunction, decreasing apoptosis, and restoring the balance of inflammatory mediators. Here, NFKB1 is linked to acute respiratory distress syndrome.